Identification of resistance mutations to crizotinib through circulating tumor cell (CTC) analysis in ALK-rearranged non-small-cell lung cancer (NSCLC)

被引：0
|
作者：
Pailler, Emma [1 ]
Faugeroux, Vincent [1 ]
Oulhen, Marianne [2 ]
Forcato, Claudio [3 ]
Laporte, Melanie [4 ]
Lecluse, Yann [4 ]
Lacroix, Ludovic [4 ]
NgoCamus, Maud [4 ]
Nicotra, Claudio [4 ]
Remon, Jordi [4 ]
Mezquita, Laura [4 ]
Planchard, David [4 ]
Soria, Jean-Charles [4 ]
Manaresi, Nicolo [3 ]
Besse, Benjamin [4 ]
Farace, Francoise [1 ]
机构：
[1] Univ Paris Saclay, Gustave Roussy, INSERM, U981, Villejuif, France
[2] INSERM, Gustave Roussy, U981, Villejuif, France
[3] Menarini Silicon Biosyst, Castel Maggiore, Italy
[4] Gustave Roussy, Villejuif, France
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3654
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy profile of Ceritinib (LDK378) in ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC)
    Chaigneau, Aurelie
    Durand, Lea
    Lallart, Audrey
    Laghouati, Salim
    Demirdjian, Sylvie
    Pinel, Sylvine
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 211 - 211
  • [32] Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports
    Michaux, Lionel
    Perrier, Alexandre
    Mehlman, Camille
    Alshehhi, Hussa
    Dubois, Antonin
    Lacave, Roger
    Coulet, Florence
    Cadranel, Jacques
    Fallet, Vincent
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism
    Zer, Alona
    Moskovitz, Mor
    Hwang, David M.
    Hershko-Klement, Anat
    Fridel, Ludmila
    Korpanty, Grzegorz J.
    Dudnik, Elizabeth
    Peled, Nir
    Shochat, Tzippy
    Leighl, Natasha B.
    Liu, Geoffrey
    Feld, Ronald
    Burkes, Ronald
    Wollner, Mira
    Tsao, Ming-Sound
    Shepherd, Frances A.
    CLINICAL LUNG CANCER, 2017, 18 (02) : 156 - 161
  • [34] Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
    Gandhi, Leena
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2012, 18 (14) : 3737 - 3742
  • [35] Small-cell transformation o f ALK-rearranged non-small-cell adenocarcinoma of the lung
    Balla, Agnes
    Khan, Farrah
    Hampel, Kenneth J.
    Aisner, Dara L.
    Sidiropoulos, Nikoletta
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2018, 4 (02):
  • [36] Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib
    Toyokawa, Gouji
    Inamasu, Eiko
    Shimamatsu, Shinichiro
    Yoshida, Tsukihisa
    Nosaki, Kaname
    Hirai, Fumihiko
    Yamaguchi, Masafumi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (07) : E55 - E57
  • [37] THE USE EXPERIENCE OF CRIZOTINIB (XALKORI®) FOR POSTOPERATIVE RECURRENCE OF ALK-REARRANGED NON-SMALL CELL LUNG CANCER
    Noma, Daisuke
    Sakamoto, Kazuhiro
    Ando, Kohei
    Amano, Shinya G.
    Sudo, Shigeto
    Goto, Hideto
    Yamakawa, Yasushi
    Tsubakihara, Motofumi
    Tsuboi, Masahiro
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1320 - S1320
  • [38] ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?
    Audigier-Vaiette, Clarisse
    Girard, Nicolas
    Cortot, Alexis B.
    Mennecier, Bertrand
    Debieuvre, Didier
    Planchard, David
    Zalcman, Gerard
    Moro-Sibilot, Denis
    Cadranel, Jacques
    Barlesi, Fabrice
    BULLETIN DU CANCER, 2014, 101 (09) : 823 - 831
  • [39] ALK-rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?
    Vergne, Florence
    Quere, Gilles
    Andrieu-Key, Sophie
    Descourt, Renaud
    Quintin-Roue, Isabelle
    Talagas, Matthieu
    Braekeleer, Marc De
    Marcorelles, Pascale
    Uguen, Arnaud
    LUNG CANCER, 2016, 91 : 67 - 69
  • [40] Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China
    Xing, Puyuan
    Wang, Shouzheng
    Wang, Qiang
    Ma, Di
    Hao, Xuezhi
    Wang, Mengzhao
    Wang, Yan
    Shan, Li
    Xin, Tao
    Liang, Li
    Liang, Hongge
    Du, Yang
    Zhang, Zhaohui
    Li, Junling
    TARGETED ONCOLOGY, 2019, 14 (03) : 325 - 333
12345